Pure Global

MiRXES CoVClear Covid-19 RT-PCR Test - Indonesia BPOM Medical Device Registration

MiRXES CoVClear Covid-19 RT-PCR Test is a medical device registered with Indonesia's BPOM (Badan Pengawas Obat dan Makanan) under Analysis ID AKL 20303220069. The device is manufactured by MIRXES PTE LTD. from Singapore, and is classified as Risk Class Kelas Resiko : B. The authorized representative in Indonesia is PT. ANDAMAN MEDICAL INDONESIA.

This page provides comprehensive regulatory information including complete registration details, manufacturer information, authorized representative details, product classification, and related products. Pure Global AI offers free access to 67,600+ Indonesia medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
BPOM Registered
Risk Class Kelas Resiko : B
MiRXES CoVClear Covid-19 RT-PCR Test
Analysis ID: AKL 20303220069

Risk Classification

Kelas Resiko : B

Product Class

Kelas : 2

Manufacturer

MIRXES PTE LTD.

Country of Origin

Singapore

Authorized Representative

PT. ANDAMAN MEDICAL INDONESIA

AR Address

Menara Cardig Lantai 1, Jalan Raya Halim Perdanakusuma

Registration Date

Mar 24, 2023

Expiry Date

Mar 08, 2025

Product Type

Serological Reagents

Respiratory viral panel multiplex nucleic acid assay

Invitro Diagnostics

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing